top of page

               Weekly Prostate Cancer Videos


Weekly Video #103:   Evaluation and Management of Recurrent Prostate Cancer Following Radiation Therapy – Summary:

Weekly Video #104:   Molecular Imaging For Staging and Advanced Disease – Axumin and PSMA:

Weekly Video #105:   Targeted Radionuclide Therapy of Prostate Cancer - Wolfgang Weber

Weekly Video #106:   Bone Metastasis: Treatments, Scans & Side Effects | Ask a Prostate Expert, Mark Scholz, MD:

Weekly Video #107:   Treating BPH: Comparing HoLEP, Rezūm, UroLift, and Aquablation:

Weekly Video #108:   MRI Versus Ultrasound for Prostate Cancer - Samir Taneja:

Weekly Video #109:   Optimal Drug Sequencing in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Evan Yu:

Weekly Video #110  What is the best vacuum device for erectile dysfunction?

Weekly Video #111:   Precision Medicine: RadioIsotopes Targeted Therapies in Cancer - Stefano Fanti:

Weekly Video #112:   The Impact of Vitamin D and Statins on Prostate Cancer Outcomes - Lorelei Mucci and Elizabeth Platz:

Weekly Video #113:   Validation of a Prognostic Genomic Classifier in Salvage Radiotherapy Prostate Cancer from a Prospective Randomized Trial - Felix Feng

Weekly Video #114:   Novel Radiopharmaceuticals In Development For Treatment in Advanced Prostate Cancer - Michael Morris:

Weekly Video #115:   The Role of FoundationOne® Liquid CDx in mCRPC - Oliver Sartor

Weekly Video #116:   MicroRNA Expression Profiles Identify Clinically Significant Prostate Cancer:

Weekly Video #117:  Clinical Implications of Genetics in Prostate Cancer Posted by A. Karim Kader, MD, PhD:

Weekly Video #118:  Considerations for the Treatment of Non Metastatic Castration-Resistant Prostate Cancer - An Interview with Maha Hussain and Tia Higano:                                                                                                                                          

Weekly Video #119:   Radiation Therapy Options for Men with Clinically Node-Positive Prostate Cancer - Mack Roach:

Weekly Video #120:   PSMA-Targeted Immune Therapy for Metastatic Castration-Resistant Prostate Cancer - Oliver Sartor:

Weekly Video #121:   Why Prostate Cancer Survivor Steve Schwartz Thinks It’s Important to Be Vigilant:

Weekly Video #122:   Hormone Therapy in Prostate Cancer | Memorial Sloan Kettering:

Weekly Video #123:   An Expert Discussion on Gleason 6 (Grade Group 1) Prostate Cancer - Scott Eggener:

Weekly Video #124:   Peyronie's Disease and Prostatectomy: what causes PD?

Weekly Video #125:   The Miracle of Radiopharmaceuticals:

Weekly Video #126:   Complications of Androgen Deprivation Therapy for Prostate Cancer - Charles Ryan:


Weekly Video #127:   Introduction to PET PSMA Gallium-68 PSMA-11 for Diagnostic Imaging of Prostate Cancer - Tom Hope:

Weekly Video #128:   Management of Oligometastatic Prostate Cancer: From Imaging to Therapy - Felix Feng:

Weekly Video #129:   Discussion from Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium:

Weekly Video #130:   Dr. Pappas talks about the benefits of a Mediterranean Lifestyle:

Weekly Video #131:   First and Only Oral GnRH Receptor Antagonist Orgovyx for the Treatment of Advanced Prostate Cancer - Charles Ryan & Alicia Morgans:                                                                                                                                                                   

Weekly Video #132:   Combining and Sequencing Therapies for Advanced Prostate Cancer   Dr. Marshall, John Hopkins:

Weekly Video #133:   Unorthodox Treatments for High-Risk Prostate Cancer | Prostate Cancer Staging Guide Dr. Scholz:

Weekly Video #134:   Testosterone Replacement in the Treatment of Advanced Prostate Cancer - Sam Denmeade and Michael Schweizer:

Weekly Video #135:   PSMA Theranostics in Prostate Cancer SNMMI - Richard Baum

Weekly Video #136:   Point Counterpoint Debate on Merits of Germline Testing for All Patients with Prostate Cancer:

Weekly Video #137:   New Advances in Next-Generation Imaging: PyL PSMA PET/CT:

Weekly Video #138:   Liquid Diagnostics and Prostate Cancer:

Weekly Video #139:    Veru-111 – Oral, targeted α & β tubulin inhibitor In Development for Prostate Cancer (mCRPC):

Weekly Video #140:   Impact of Concomitant Prostate Cancer Therapy of Relugolix in Men with Advanced Prostate Cancer - Daniel J. George:

Weekly Video #141:   Discussing the Efficacy and Safety from Results of the Dose Escalation Arm of AMG 160, a Bispecific T-Cell Engager (BiTE) Immune Therapy Targeting PSMA for Metastatic Castration-Resistant Prostate Cancer - Ben Tran, Oliver Sartor, and Neal Shore:

Weekly Video #142:   PROSPER Trial Demonstrates the Relationship Between the Degree of PSA Decline and Survival Outcomes - Cora Sternberg

Weekly Video #143:   177 Lu-PSMA-617 Offers a Promising Treatment for Men with Progressing mCRPC. - Declan Murphy & Michael Hofman:

Weekly Video #144:   Steps to Find a Clinical Trial:

Weekly Video #145:   The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer - Matthew Deek & Phuoc Tran:

Weekly Video #146:   Patient Selection for ADT Treatment with the Oral GnRH Antagonist in Clinical Practice - Ashley Ross:

Weekly Video #147:   The Biology of Prostate Cancer Metastasis and What PSMA Imaging Is Teaching Us: Presentation and Discussion - Kenneth J. Pienta:

Weekly Video #148:   Increased Risk for CV Disease in Men with Prostate Cancer - Alicia Morgans and Oliver Sartor:

Weekly Video #149:    TRANSFORMER - A Study Comparing Bipolar Androgen Therapy Vs Enzalutamide in mCRPC - Emmanuel Antonarakis:

Weekly Video #150:    The TRANSFORMER Study: Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With mCRPC:

Weekly Video #151:   PYLARIFY®, F 18-labeled PSMA Targeted PET Gains US FDA Approval - Michael Morris:

Weekly Video #152:   Intensification of Hormonal Therapy for Men With Metachronous Metastatic Hormone-Sensitive Disease – Chris Sweeney

Weekly Video #153:    Real-World Evidence For Patients with mCRPC Treated with Cabazitaxel - Ronald de Wit:

Weekly Video #154:   First Results of PEACE-1 A Phase 3 Trial with a 2x2 Factorial Design of Abiraterone Acetate plus Prednisone and/or Local Radiotherapy in Men with De Novo Metastatic Castration-Sensitive Prostate Cancer mCSPC - Karim Fizazi:

Weekly Video #155:   Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers on the Cardiovascular System Effects and Modifications - Alicia Morgans:

Weekly Video #156:   Radiation Therapy Options for Men with Clinically Node-Positive Prostate Cancer - Mack Roach:

Weekly Video #157:   Clinical Case Discussions - "Rising PSA 18 Months Post RP and Timing of Radiotherapy" - Ashley Ross, Alan Dal Pra, and Dan Spratt:

Weekly Video #158:   Promising Studies In Prostate Cancer | A 2021 ASCO Update | Mark Scholz, MD:

Weekly Video #159:   How to Prevent Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD:

Weekly Video #160:   Empowerment and Focus - Navigating a Terminal Prostate Cancer Diagnosis - Cameron Upton:

Weekly Video #161:   First-in-Human Study of FOR46 in Men With Metastatic Castration Resistant Prostate Cancer (mCRPC) – Rahul Aggarwal:

Weekly Video #162:   STAMPEDE Analysis of Abiraterone With or Without Enzalutamide Added to Androgen Deprivation Therapy Compared to ADT Alone In High-Risk Non-Metastatic Prostate Cancer Patients– Gerhardt Attard:

Weekly Video #163:   Researchers say new blood test can spot more than 50 types of cancer — many hard to detect early:

Weekly Video #164:   Understanding Genetic Testing by Color:

Weekly Video #165:   Can we eat to starve cancer? - William Li:

Weekly Video #166:   Genomic Profiling: Germline and Somatic Testing - What You Must Know Today - Emmanuel Antonarakis:

Genomic Profiling: Germline and Somatic Testing - What You Must Know Today - Emmanuel Antonarakis (

Weekly Video #167:   PSMA-targeted PET Imaging of Prostate Cancer - A Primer for Urologists - Michael Gorin:

PSMA-targeted PET Imaging of Prostate Cancer - A Primer for Urologists - Michael Gorin (

Weekly Video #168:   Breakthroughs in Technology for Cancer Screening and Cancer Therapies - A Discussion Francis deSouza (

Weekly Video #169:   High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack (

Weekly Video #170:   Updates in mpMRI | Dr. Greene | Video (

Weekly Video #171:   PSMA PET in the Metastatic Castration-Resistant Prostate Cancer Setting - Oliver Sartor (

Weekly Video #172:   The History of Radiopharmaceuticals in Prostate Cancer - Neil Bander (

Weekly Video #173:   Chesapeake Urology Nutrition Program for Prostate Cancer Recovery Presented by David A. Levy, MD - YouTube

Weekly Video #174:   GU ASCO Symposium 2022 Summary (\

Weekly Video #175:   Point-Counterpoint: Management of mCRPC (

Weekly Video #176:   NCCN Guidelines On PSMA Molecular Imaging - Tanya Dorff (

Weekly Video #177:   Darolutamide and Survival in Metastatic Hormone-Sensitive Prostate Cancer - ARASENS Trial - Karim Fizazi (

Weekly Video #178:   Pluvicto The First Targeted Radioligand Therapy for Treatment of Metastatic Castration-Resistant Prostate Cancer FDA Approved - Charles Ryan and Alicia Morgans (

Weekly Video #179:   Pluvicto™ (177Lu-PSMA-617) Indications for Clinical Use in PSMA Positive Metastatic Castration-Resistant Prostate Cancer mCRPC - Oliver Sartor:

Weekly Video #180:   The role of doublet and triplet therapies in prostate cancer (

Weekly Video #181:   Ongoing Clinical Trials Evaluating The Efficacy of Targeted Radioligand Therapy - Shahneen Sandhu (

Weekly Video #182:   Practice Changing Data from ARASENS - Statistically Significant Overall Survival - Fred Saad, Bertrand Tombal, and Neal Shore (

Weekly Video #183:   High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack (

Weekly Video #184:   Penile Squamous Cell Carcinoma Somatic Alterations - W. Michael Korn (

Weekly Video #185:   The State of Bipolar Androgen Therapy in Prostate Cancer - Emmanuel Antonarakis (

Weekly Video #186:   Beyond PSMA - New Targets in Prostate Cancer - Tanya Dorff (

Weekly Video #187:   Treatment of Unfavorable Intermediate Risk Prostate Cancer - Ashley Ross, Jason Hafron, and Katie Murray (

Weekly Video #188:   ConfirmMDX & Improving Identification of Risk for Clinically Significant PCa (

Weekly Video #189:   (4399) Burning Questions and Controversies in the Management of Advanced Prostate Cancer Patients - YouTube

Weekly Video #190:   (4400) New Study Shows The Impact of Diet on Prostate Cancer | Mark Scholz, MD | PCRI - YouTube

Weekly Video #191:   (4408) Prostate Cancer and Gleason Score or Group Video - YouTube

Weekly Video #192:   Darolutamide Approved for Patients with mHSPC - Charles Ryan (

Weekly Video #193:   What's Next for Radiotheranostics in Prostate Cancer? | Video (

Weekly Video #194:   The Use of the Decipher Biopsy Test Prior to Prostatectomy - Ashley Ross (

Weekly Video #195:   Importance of Lifestyle and Prevention of Complications in Advanced Prostate Cancer: How to Take Care of Brain and Mood? Presentation APCCC 2022 - Charles Ryan (

Weekly Video #196:   Brachytherapy: What's New and Where are We Going? | Video (

Weekly Video #197:   Depression, Bone Health and Exercise in Prostate Cancer - Fred Saad, Tomasz Beer & Charles Ryan (

Weekly Video #198:   Reducing Side Effects of Hormone Therapy for Prostate Cancer | Prostate Cancer Staging Guide  Dr. Scholz,

Weekly Video #199:   Hormonal Therapy for Prostate Cancer:

Weekly Video #200:   Physical and Mental Wellness in Prostate Cancer:

Weekly Video #201:   Immune Checkpoint B7-H3 - APCCC 2022 - Emmanuel Antonarakis (

Weekly Video #202:   The Future of Radiopharmaceuticals in the Treatment of Prostate Cancer - Philip Kantoff (

Weekly Video #203:   Timing and Intensity of ADT in Biochemical Recurrence - Channing J. Paller (

bottom of page